Programmed repair of disease-causing UGA premature termination codons in mammalian brain
Nucleic Acids Research · 03.07.2026 · 54 (13)
DOI: 10.1093/nar/gkag695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 16.07.2026. Verfasst von Ahmad Al Saneh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States. Hauptthemen laut MEDLINE: Brain, RNA, Transfer, Codon, Nonsense, Genetic Therapy. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Simons Foundation Autism Research Initiative-Pilot Award, Simons Foundation.
Abstract (Originalsprache)
Protein-truncating variants caused by stop codons are the most prevalent class of rare variant mutations in neurodevelopmental diseases, with UGA codons being most common. Suppressor transfer RNA (sup-tRNA) has therapeutic potential for premature termination codon (PTC) rescue but has thus far underperformed by traditional AAV delivery platforms, and progress has been hampered by the lack of methods to non-invasively assess in vivo activity in mammalian brain. To fill this material gap, we utilize transcranial in vivo bioluminescence imaging data from a luciferase-UGA mouse model to optimize viral payloads with sup-tRNA genes. These data demonstrate that U6 promoter-driven and single-stranded AAV2/9 constructs show variable and dose-dependent activity, whereas self-complementary AAV2/9 with the tRNA in a minimal 100-bp genomic context provides broad and efficacious PTC rescue. Further, payload tRNA multiplexing and use of tRNA introns enable efficacy of low viral titers and sustained rescue. tRNA sequencing of scAAV-delivered ArgUCA sup-tRNA in brain demonstrates no effects on endogenous tRNA levels, their acylation, or processing, and these features are also maintained in the delivered ArgUCA sup-tRNA. Collectively, this work defines a scalable strategy for precision UGA PTC stop codon suppression, supporting development of durable genetic rescue therapies for neurodevelopmental disorders in the mammalian brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States.
ORCID-Profile: Christopher A Ahern
Förderung
- NICHD NIH HHS
- Simons Foundation Autism Research Initiative-Pilot Award
- Simons Foundation
- Developmental Disabilities Research Center
Zitieren
APA
Al Saneh, A., Gissot, L., & Ahern, C. A. (2026). Programmed repair of disease-causing UGA premature termination codons in mammalian brain. Nucleic Acids Research, 54(13). https://doi.org/10.1093/nar/gkag695
Vancouver
Al Saneh A, Gissot L, Ahern CA. Programmed repair of disease-causing UGA premature termination codons in mammalian brain. Nucleic Acids Research. 2026;54(13). doi:10.1093/nar/gkag695
BibTeX
@article{AlSaneh2026,
author = {Al Saneh, Ahmad and Gissot, Lionel and Ahern, Christopher A},
title = {Programmed repair of disease-causing UGA premature termination codons in mammalian brain},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {13},
doi = {10.1093/nar/gkag695}
}
EUVIMED